首页> 美国卫生研究院文献>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease >Peptidyl‐Prolyl Isomerase 1 Regulates Ca2+ Handling by Modulating Sarco(Endo)Plasmic Reticulum Calcium ATPase and Na2+/Ca2+ Exchanger 1 Protein Levels and Function
【2h】

Peptidyl‐Prolyl Isomerase 1 Regulates Ca2+ Handling by Modulating Sarco(Endo)Plasmic Reticulum Calcium ATPase and Na2+/Ca2+ Exchanger 1 Protein Levels and Function

机译:肽基脯氨酰异构酶1通过调节Sarco(Endo)血浆网状钙ATPase和Na2 + / Ca2 +交换子1蛋白的水平和功能来调节Ca2 +的处理。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAberrant Ca2+ handling is a prominent feature of heart failure. Elucidation of the molecular mechanisms responsible for aberrant Ca2+ handling is essential for the development of strategies to blunt pathological changes in calcium dynamics. The peptidyl‐prolyl cis‐trans isomerase peptidyl‐prolyl isomerase 1 (Pin1) is a critical mediator of myocardial hypertrophy development and cardiac progenitor cell cycle. However, the influence of Pin1 on calcium cycling regulation has not been explored. On the basis of these findings, the aim of this study is to define Pin1 as a novel modulator of Ca2+ handling, with implications for improving myocardial contractility and potential for ameliorating development of heart failure.
机译:背景异常的Ca 2 + 处理是心力衰竭的重要特征。阐明引起Ca 2 + 异常处理的分子机制,对于制定钝化钙动力学病理变化的策略至关重要。肽基脯氨酰顺反异构酶肽基脯氨酰异构酶1(Pin1)是心肌肥大发展和心脏祖细胞周期的关键介体。但是,尚未研究Pin1对钙循环调节的影响。基于这些发现,本研究的目的是将Pin1定义为Ca 2 + 处理的新型调节剂,对改善心肌收缩力和改善心力衰竭的发展具有潜在意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号